Table 3.

Relationship between the expression of hTRTmRNA, hTRT protein and clinicopathological parameters in gastric cancer

Parameters	n	hTRTmRNA positive (%)	P	hTRT protein positive(%)	P
Gender
Male	42	35 (83.3)	0.309	39 (92.9)	0.180
Female	11	7(63.6)		8 (72.7)
Age(years)
<55	25	18 (72.0)	0.219	20 (80.0)	0.147
≥ 55	28	24 (85.7)		27 (96.4)
Tumor size(cm)
< 5	24	20 (83.3)	0.735	22 (91.7)	0.678
≥ 5	29	22 (75.9)		25 (86.2)
Tumor location
Cardia	26	23 (88.5)	0.128	24 (92.3)	0.529
Body	16	10 (62.5)		13 (81.3)
Antrum	11	9 (81.8)		10 (90.9)
Lymph node metastasis
Absent	25	18 (72.0)	0.219	20 (80.0)	0.089
Present	28	24 (85.7)		27 (96.4)
Invasion depth
Not invading serosa	8	7(87.5)	0.879	7 (87.5)	1.000
Invading serosa	45	35 (77.8)		40 (88.9)
Clinical stage
I and II	47	37 (78.7)	1.000	41 (87.2)	0.806
III and IV	6	5 (83.3)		6 (100.0)